Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Israel

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2004
Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinomaK Tharp, O Israel, J Hausmann, et al.
Radiology|February 1, 1992
Lymphoma: predictive value of Ga-67 scintigraphy after treatmentD Front, S Ben-Haim, O Israel, et al.
Clinical Nuclear Medicine|May 1, 1990
Normal and abnormal Ga-67 SPECT anatomy in patients with lymphomaO Israel, J Jerushalmi, S Ben-Haim, et al.
Radiology|May 1, 1990
Ga-67 SPECT before and after treatment of lymphomaD Front, O Israel, R Epelbaum, et al.
Pediatric Hematology and Oncology|June 13, 2001
Detection of isolated distant metastasis in soft tissue sarcoma by fluorodeoxyglucose positron emission tomography: case reportM W Ben Arush, O Israel, Z Kedar, et al.
Cancer|June 15, 1988
Gallium 67 imaging in monitoring lymphoma response to treatmentO Israel, D Front, M Lam, et al.
Seminars in Nuclear Medicine|January 1, 1989
A practical SPECT technique for quantitation of drug delivery to human tumors and organ absorbed radiation doseG Iosilevsky, O Israel, A Frenkel, et al.
Cancer|May 15, 1991
In vivo measurements of the fraction of dose of bleomycin labeled with cobalt 57 delivered to human tumorsD Front, E Even-Sapir, O Israel, et al.
Radiology|October 1, 1987
Human lung tumors: SPECT quantitation of differences in Co-57 bleomycin uptakeD Front, O Israel, G Iosilevsky, et al.
Radiology|April 20, 1999
Hodgkin disease: prediction of outcome with 67Ga scintigraphy after one cycle of chemotherapyD Front, R Bar-Shalom, M Mor, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2004
Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinomaK Tharp, O Israel, J Hausmann, et al.
Radiology|February 1, 1992
Lymphoma: predictive value of Ga-67 scintigraphy after treatmentD Front, S Ben-Haim, O Israel, et al.
Clinical Nuclear Medicine|May 1, 1990
Normal and abnormal Ga-67 SPECT anatomy in patients with lymphomaO Israel, J Jerushalmi, S Ben-Haim, et al.
Radiology|May 1, 1990
Ga-67 SPECT before and after treatment of lymphomaD Front, O Israel, R Epelbaum, et al.
Pediatric Hematology and Oncology|June 13, 2001
Detection of isolated distant metastasis in soft tissue sarcoma by fluorodeoxyglucose positron emission tomography: case reportM W Ben Arush, O Israel, Z Kedar, et al.
Cancer|June 15, 1988
Gallium 67 imaging in monitoring lymphoma response to treatmentO Israel, D Front, M Lam, et al.
Seminars in Nuclear Medicine|January 1, 1989
A practical SPECT technique for quantitation of drug delivery to human tumors and organ absorbed radiation doseG Iosilevsky, O Israel, A Frenkel, et al.
Cancer|May 15, 1991
In vivo measurements of the fraction of dose of bleomycin labeled with cobalt 57 delivered to human tumorsD Front, E Even-Sapir, O Israel, et al.
Radiology|October 1, 1987
Human lung tumors: SPECT quantitation of differences in Co-57 bleomycin uptakeD Front, O Israel, G Iosilevsky, et al.
Radiology|April 20, 1999
Hodgkin disease: prediction of outcome with 67Ga scintigraphy after one cycle of chemotherapyD Front, R Bar-Shalom, M Mor, et al.
Pageof 11